$145.58-0.86 (-0.59%)
The Procter & Gamble Company provides branded consumer packaged goods worldwide.
The Procter & Gamble Company in the Consumer Defensive sector is trading at $145.58 with a market capitalization of $337.1B. Wall Street consensus targets $160.61 (23 analysts), implying a +10.3% move over the next 12 months. The stock is currently 13% below its 52-week high of $167.25, remaining 0.2% below its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the safe zone. The Whystock Score of 75/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $21.20B↓ | $21.23B↓ | $22.21B↓ | $22.39B↑ | $20.89B |
| Gross Profit | $10.28B↓ | $10.51B↓ | $11.37B↓ | $11.50B↑ | $10.26B |
| Operating Income | $3.95B↓ | $4.58B↓ | $5.37B↓ | $5.86B↑ | $4.35B |
| Net Income | $3.04B↓ | $3.93B↓ | $4.32B↓ | $4.75B↑ | $3.62B |
The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The company offers conditioners, shampoos, stylin...

During the September 3 episode of Mad Money, a caller asked for Jim Cramer’s current opinion of The Procter & Gamble Company (NYSE:PG), and he replied: Okay, this is something Jeff Marks and I from the club kick around, and we’re both kind of heartsick about it. We know that Procter has no growth. So […]

KVUE nears its planned combination after shareholder and U.S. antitrust clearances, while margin, debt and legal risks temper the Q4 2026 outlook.

Kenvue's profit margins and cash flow improved in the first half, but modest sales growth, debt and uneven segment trends keep the risk-reward balanced.

PG faces a $1.4 billion after-tax earnings headwind in fiscal 2027 as rising costs, FX pressure and other factors weigh on margins.

Three defensive blue chips entered 2026 promising safety, but their returns split into wildly different tiers, and the reason one name lapped the others exposes a fault line in how investors define defensive in the first place.
Academic risk and quality models computed from PG's own filings and price history, not from analyst opinion.
Mixed: 6 of 9 fundamental-health tests pass, so profitability and balance-sheet trends disagree.
Altman Z above the 2.99 safe threshold, so the model puts bankruptcy risk in its lowest band.
Beneish M below the -1.78 flag threshold, so the earnings-manipulation model finds nothing unusual in the accruals and margin trends.
Share of earnings coming from accruals rather than cash. Higher values historically precede weaker future returns.
GARCH(1,1) 30-day annualised forecast, above the current 17.6% reading.
Fama-French 5-factor market beta. The five factors explain 23% of this stock's return variance; the rest is idiosyncratic.
The stock’s own historical valuation anchor, which is a fairer comparison than a sector average for a company with a persistent premium or discount.
Model inputs as of 2026-09-08.